Martin Jelsma argues that the WHO’s decision to maintain the plant's international scheduling disregards scientific evidence and Indigenous Peoples’ rights, reflecting inconsistencies in the UN drug control system and the need for reform.
Drugreporter does a guided tour of Bergen’s pioneering HABIB clinic, highlighting how HAT can improve the health and wellbeing of people with long-term opioid dependence.
The Court argued that by criminalising DULF's community-led compassion club, which saved lives, reduced harms and did not affect public safety, the current legal framework violated fundamental rights.
IDPC and partners welcomed the UN EMLER’s recognition of systemic racism in drug law enforcement and called for urgent action to address the racialised impacts of punitive drug policy.
IDPC, formerly incarcerated women and civil society partners call for drug policies rooted in care rather than punishment, with women with lived experience at the centre of policymaking and greater action to address gender and structural inequalities.
Dejusticia, Elementa and IDPC denounce plans to resume the use of hazardous herbicides in eradication efforts due to serious risks to rights, environment and communities' livelihoods.
Civil society, communities and other stakeholders are invited to submit evidence, experiences and recommendations to the CND Expert Panel, as it considers the future of the UN drug control system ahead of the 2029 high-level review.
One year after Louise Vincent’s death, the drug user movement she helped build is reckoning with the loss of a visionary organiser who championed harm reduction, human rights and the collective power of people who use drugs.
Opium poppy cultivation shows expansion across Afghanistan, Pakistan and Iran, as economic pressures, changing practices and prohibition reshape markets.
UN experts condemn US military strikes on suspected drug-trafficking vessels, stressing that enforcement responses to trafficking are governed by human rights law.
In conversation with IDPC's outgoing Executive Director Ann Fordham, Kojo Koram explores the forces shaping drug policy’s future, from colonialism and racialised criminalisation to corporate capture and reparative measures.
The rapid expansion of Europe's cocaine markets highlights the limitations of supply-side enforcement and strains already insufficient health responses.
